Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Philips Halts Distribution of Tack Endovascular System
OEM News

Philips Halts Distribution of Tack Endovascular System Over Class I Recall

The recall was initiated following reports of user challenges from customers, including events where further interventions were needed to retrieve or remove the Tack implant

The Tack endovascular system. Photo: FDA.

Philips is recalling the Tack endovascular system due to challenges experienced by customers during use. The Tack system is used to treat blood vessel dissection after they’re widened using a balloon or stent. The implant attaches damaged tissue to the blood vessel’s inner lining to repair dissection.

The Tack endovascular system is made by Intact Vascular, and distributed by Philips.

The recall was initiated following reports of user challenges from customers, including events where further interventions were needed to retrieve or remove the Tack implant. Using the product has the short-term risks of partial or complete occlusion, arterial dissection or perforation. Long-term risks include pain, tissue loss, restenosis, need for bypass surgery, amputation, and death.

This Class I recall—the most serious type—involves removing devices from where they’re used or sold. Philips urged that all customers should stop using the Tack system immediately and the company will no longer distribute it for use.

There have thus far been 20 reported injuries, with no reports of death due to the issue.

Philips’ January 10 Urgent Medical Device Recall letter advised customers to quarantine affected devices and not to open or use identified products. The response form attached to the letter should be completed, returned and signed within a week. The return and credit process will begin based on the completed form.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters